For young patients with primary multimetastatic Ewing sarcoma, pazopanib is well-tolerated and effective, according to a ...
Shanghai Pharmaceuticals Holding Co Class H (($SHPMF)) announced an update on their ongoing clinical study. Shanghai Pharmaceuticals Holding Co.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback